6.65
price down icon7.64%   -0.55
pre-market  Pre-mercato:  6.71   0.06   +0.90%
loading

Liminatus Pharma Inc Borsa (LIMN) Ultime notizie

pulisher
Jul 12, 2025

Liminatus Pharma (NASDAQ:LIMN) Upgraded at Wall Street Zen - Defense World

Jul 12, 2025
pulisher
Jul 11, 2025

Liminatus Pharma appoints Philip Lemons and Richard Baek to board of directors - Investing.com

Jul 11, 2025
pulisher
Jul 11, 2025

Liminatus Pharma Expands Board with Two New Directors - TipRanks

Jul 11, 2025
pulisher
Jul 11, 2025

Liminatus Pharma, Inc.Class A Common Stock (Nasdaq:LIMN) Stock Quote - FinancialContent

Jul 11, 2025
pulisher
Jul 10, 2025

Liminatus Pharma Stock Soars 18.58% on Rebranding - AInvest

Jul 10, 2025
pulisher
Jul 09, 2025

Liminatus Pharma Stock Soars 14.97% on Healthcare Sector Optimism - AInvest

Jul 09, 2025
pulisher
Jul 07, 2025

Medicus Pharma Soars 10.95% on Acquisition News - AInvest

Jul 07, 2025
pulisher
Jul 04, 2025

Liminatus Pharma's Pancreatic Cancer Diagnostic Consortium: A Strategic Pivot for Market Leadership? - AInvest

Jul 04, 2025
pulisher
Jul 03, 2025

Liminatus Pharma sees stock surge on pancreatic cancer diagnostic kit collaboration - grafa.com

Jul 03, 2025
pulisher
Jul 03, 2025

Liminatus Pharma Forms Consortium To Advance Diagnostic Kit For Early Pancreatic Cancer Detection - MarketScreener

Jul 03, 2025
pulisher
Jul 03, 2025

Liminatus Pharma Warrant Holder Alleges Blocked Share Purchases - Bloomberg Law News

Jul 03, 2025
pulisher
Jul 03, 2025

Liminatus Pharma forms consortium for pancreatic cancer diagnostic kit By Investing.com - Investing.com UK

Jul 03, 2025
pulisher
Jul 03, 2025

Liminatus Pharma Forms R&D Consortium for Cancer Diagnostics - TipRanks

Jul 03, 2025
pulisher
Jul 02, 2025

Liminatus Pharma Stock Soars 14.49% on 10K Filing - AInvest

Jul 02, 2025
pulisher
Jun 30, 2025

Klotho Neurosciences Surges: What’s Driving the Gains? - timothysykes.com

Jun 30, 2025
pulisher
Jun 26, 2025

Liminatus Pharma files to sell 6.9M shares of common stock - MSN

Jun 26, 2025
pulisher
Jun 25, 2025

Liminatus Pharma Stock Soars 29.36% on Nasdaq Listing - AInvest

Jun 25, 2025
pulisher
Jun 24, 2025

Carnival Posts Better-Than-Expected Earnings, Joins… - inkl

Jun 24, 2025
pulisher
Jun 18, 2025

Why Beyond Air Shares Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket - Benzinga

Jun 18, 2025
pulisher
Jun 12, 2025

Why Is Liminatus Pharma Inc (LIMN) Up 83%? Unpacking the Surge - Wealth Daily

Jun 12, 2025
pulisher
Jun 12, 2025

KH Group's investment in US biotech Liminatus Pharma halves in one day - Chosun Biz

Jun 12, 2025
pulisher
Jun 12, 2025

Why Oracle Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga

Jun 12, 2025
pulisher
Jun 09, 2025

Liminatus Pharma Plunges 12.06% Despite Regulatory Compliance - AInvest

Jun 09, 2025
pulisher
Jun 08, 2025

Liminatus Pharma Stock Surges to Record High After Regaining Nasdaq Compliance - MSN

Jun 08, 2025
pulisher
Jun 07, 2025

Liminatus Pharma stock gains on regaining compliance with Nasdaq - MSN

Jun 07, 2025
pulisher
Jun 06, 2025

Liminatus Pharma Plunges 15.24% on Volatility Pause - AInvest

Jun 06, 2025
pulisher
Jun 05, 2025

Greif Posts Upbeat Earnings, Joins Planet Labs PBC, IperionX, Owens & Minor And Other Big Stocks Moving Higher On Thursday - Benzinga

Jun 05, 2025
pulisher
Jun 05, 2025

Crude Oil Moves Higher; Ciena Posts Downbeat Earnings - Benzinga

Jun 05, 2025
pulisher
Jun 05, 2025

Dow Dips Over 100 Points; US Jobless Claims Increase - Benzinga

Jun 05, 2025
pulisher
Jun 05, 2025

Liminatus Pharma shares soar on Nasdaq compliance news By Investing.com - Investing.com Canada

Jun 05, 2025
pulisher
Jun 05, 2025

Liminatus Pharma shares soar on Nasdaq compliance news - Investing.com Australia

Jun 05, 2025
pulisher
Jun 05, 2025

Pre-market Movers: LIMN, KRON, HSDT, CBUS... - RTTNews

Jun 05, 2025
pulisher
Jun 05, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Jun 05, 2025
pulisher
Jun 05, 2025

Liminatus Pharma Gains Compliance With Nasdaq Filing Requirements; Shares up Pre-Bell - marketscreener.com

Jun 05, 2025
pulisher
Jun 04, 2025

Liminatus Pharma regains Nasdaq listing compliance - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Liminatus Pharma Regains Nasdaq Compliance After Filing Delay - TipRanks

Jun 04, 2025
pulisher
May 15, 2025

Liminatus Pharma Delays Quarterly Report Filing - TipRanks

May 15, 2025
pulisher
May 14, 2025

Liminatus Pharma’s Merger with Iris Acquisition Corp. - Global Legal Chronicle

May 14, 2025
pulisher
May 01, 2025

Iris Acquisition, Liminatus Pharma Sign SPAC Merger Deal - marketscreener.com

May 01, 2025
pulisher
May 01, 2025

LIMN Stock Price and Chart — NASDAQ:LIMN - TradingView

May 01, 2025
pulisher
Mar 10, 2025

Iris Acquisition Corp confirms delisting and shareholder vote outcomes - Investing.com

Mar 10, 2025
pulisher
Jan 28, 2025

Iris Acquisition Corp announces preliminary proxy statement - Investing.com

Jan 28, 2025
pulisher
Nov 11, 2024

Iris Acquisition Corp announces business combination - Investing.com

Nov 11, 2024
pulisher
Aug 07, 2024

Iris Acquisition Corp announces business combination with Liminatus Pharma - Investing.com

Aug 07, 2024
pulisher
Dec 05, 2022

New company Liminatus Pharma Inc to develop three cancer treatments - Labiotech.eu

Dec 05, 2022
pulisher
Dec 02, 2022

A fledgling biotech goes SPAC route to bankroll cancer vaccine, CAR-T and CD47 - Endpoints News

Dec 02, 2022
pulisher
Dec 01, 2022

Liminatus Pharma and Iris Acquisition to Combine in $334M Deal - The SPAC Conference

Dec 01, 2022
pulisher
Nov 30, 2022

Liminatus Pharma LLC and Iris Acquisition Corp to combine to incorporate and accelerate much-needed cancer treatments - Business Wire

Nov 30, 2022
pulisher
Mar 20, 2017

Holland & Knight Partner Seth Belzley Ranked Among Denver’s Outstanding "40 Under 40" Business Professionals - Holland & Knight

Mar 20, 2017
$21.40
price down icon 2.10%
$35.84
price down icon 0.78%
$25.00
price down icon 3.40%
$98.18
price up icon 1.57%
$112.89
price down icon 0.90%
biotechnology ONC
$250.30
price down icon 1.22%
Capitalizzazione:     |  Volume (24 ore):